Cosentyx 150 mg, Pulver zur Herstellung einer Injektionslösung - Durchstechflasche(n) Swissmedic Key 63295001 PP Registration Holder Novartis Pharma Schweiz AG Name Cosentyx 150 mg, Pulver zur Herstellung einer Injektionslösung Date of registration 20.02.2015 Introduction of Sequence 20.02.2015 ATC-Classification Secukinumab (L04AC10) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.15. Show package size Durchstechflasche(n) Index Therapeuticus (Swissmedic) 07.15. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 538.86 Limitation Yes Limitation text
Deductible 10 % Consumer price 602.45 Feedback FB Daily cost GTIN 7680632950015 Medication Code Biotechnologika Pharmacode 6269861 Disponibility
Composition Praeparatio cryodesiccata: secukinumabum 150 mg, saccharum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, pro vitro. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Dry substance Excipiens Active Agent Dose Secukinumabum 150 mg
BAG: Active Agent Dose Secukinumabum 150 mg
Inactive agents Histidin Hydrochloride Monohydrate Histidine Polysorbatum 80 Saccharum
Source Data was imported : 05.09.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
